Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients

NCT01021943 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant

Interventions

DRUG: spironolactone
DRUG: Placebo

Sponsor

Instituto Nacional de Cardiologia Ignacio Chavez